Cross border Medical Assessment Service Platform

The direct path to advanced healthcare in China

We are a cross-border medical assessment and full process service platform for complex patients and families in Asia. Starting from structured medical record evaluation, it helps patients determine whether they are suitable for cross-border referral, when to refer, what type of medical resources to match, and provides full process support from pre diagnosis evaluation, in diagnosis collaboration to post diagnosis follow-up. We believe that our services can help patients obtain clearer, more independent, and responsible judgments before making major medical decisions.

Non-medical intermediary
scientific evaluation
full-service
10,000+ patient
50+ country
98% satisfaction
我们是谁

About PrimePath

In medical decision-making, what is truly important is not more choices, but more accurate judgments

微信图片_20260519115803_164_53.png

微信图片_20260519170126_489_10.png

       

        PrimePath is a professional organization headquartered in Singapore that specializes in cross-border medical services in the Asia Pacific region, connecting advanced medical resources in China with the needs of Asian patients for a long time. Relying on a service network covering multiple countries, a cooperative hospital system, insurance payment channels, and medical evaluation mechanisms, we provide more orderly cross-border medical collaboration support for patients with complex conditions, cooperative hospitals, insurance institutions, and local doctors.

       Our core value is not simply to facilitate referrals, but to reduce information asymmetry, selection risks, and execution costs for patients in cross-border healthcare through professional evaluation, resource matching, and full process execution, allowing truly suitable patients to enter more appropriate medical pathways.

Non-medical intermediary

Why evaluate first and then refer?

For patients with complex medical conditions, cross-border healthcare is not simply about choosing a hospital, but a comprehensive decision involving disease diagnosis, treatment timing, resource matching, and execution capabilities. PrimePath uses a standardized evaluation process to first determine whether a patient is suitable for cross-border treatment, and then matches the corresponding hospital, experts, and service paths to avoid blind referrals, resource mismatches, and unnecessary time costs.

Key evaluation directions

Complex medical conditions should not be judged from the perspective of "treatment items"

PrimePath focuses on assisting patients and families in evaluating cross-border medical adaptability in complex medical scenarios, including whether referral is suitable, when referral should be made, what medical resources should be matched, and how to collaborate in the future.

Our differentiation advantage

Assessment Before Referral

Structured Access to Advanced Care

Patient Interest First

Continuity Across the Whole Journey

Why choose us

Why choose PrimePath?

We do not create anxiety and do not provide blind referrals. PrimePath helps patients make clear, independent, and high-quality decisions through scientific assessment and end-to-end services.

Scientific evaluation system

Feasibility assessment based on evidence-based medicine to help you make scientific decisions instead of blindly referring patients

Authoritative expert team

Top medical experts provide objective evaluations rather than commercial recommendations

Transparent fee structure

Transparent pricing with no hidden fees. Pay the evaluation fee first, and then decide whether to receive treatment

end-to-end service

Full support from pre diagnosis assessment to post diagnosis rehabilitation to ensure treatment effectiveness

Objective evaluation
24/7 support
Transparent process

98%

patient satisfaction

50+

cooperative hospital

200+

expert physician

10K+

Evaluated patient

Rumah Sakit

cooperative hospital

Top medical institutions in China

Our Team

Expert team

Gathering top medical experts in China to provide you with authoritative diagnosis and treatment evaluations

Chen Xiong
4.9

Qian faces south

Chief Physician

Diagnosis and treatment of nasopharyngeal carcinoma proton radiation therapy
29 years of clinical experience
View materials
Chen Xiong
4.9

Shen Lin

Chief Physician

Digestive Oncology Department Digestive Oncology Research Center Early Clinical Research Center
25 years of clinical experience
View materials
Chen Xiong
4.9

Guo Jun

Chief Oncologist

Department of Melanoma and Sarcoma Department of Urology and Oncology
23 years of clinical experience
View materials
Chen Xiong
4.9

Zhang Yongjie

Chief Physician

Leader of Oncology Surgery Pancreatic Surgery Department Fudan University Affiliated Cancer Hospital
27
View materials
Chen Xiong
4.9

Xu Qing

Chief Physician

Discipline leader of Oncology Department and Biological Therapy Center
Tumor immunotherapy, targeted therapy, solid malignant tumors such as pelvic malignancies and lung cancer
View materials
Chen Xiong
4.9

Ke Xiaoyan

Chief Physician

Lymphoma and Myelomatology Department
27
View materials
Chen Xiong
4.9

Mayou Steel

Chief Physician

Liver gallbladder pancreas spleen gastrointestinal thyroid and breast surgery
30
View materials
Chen Xiong
4.9

Zou Yinghua

Chief Physician

Leader of Minimally Invasive Treatment and Tumor Intervention Science Department
27
View materials
Chen Xiong
4.7

Lu Ming

Chief Physician

Gastric cancer colorectal cancer neuroendocrine tumors and other malignant tumors of the digestive system
21
View materials
Testimonials

Patient stories

Real case studies witness the value of scientific evaluation and full process services

Amin

Mr. Fang

China62 years oldyear
Lung cancer with meningeal metastasis

Mr. Fang

方先生,中国人,肺癌合并脑膜转移62岁的方先生(化名)踏上抗癌征程已经五年。这期间,他的抗癌历程并非一帆风顺,而是充满了各种变数,从确诊时的状况,到后续多次治疗出现转折,都见证着他与病魔抗争的不易。病情进展与病例转化:挑战接踵而来2020年9月,方先生被确诊为肺腺癌且伴有EGFR 21外显子L858R突变。面对这突如其

The doctors here take care of us like family. We have expectations and a feeling in our hearts that we will gradually get better

More stories

Amin
germ cell tumor

Xiao Zheng

Indonesia

Amin
Acute T-cell leukemia

Marina

Russia

Amin
Chordoma

Rafi

Indonesia

How It Works

Assessment process for medical treatment in China

A simple, transparent process designed for your comfort and peace of mind

Step 1

Appointment evaluation

Contact your online service advisor

Step 2

expert evaluation

Expert team analyzes medical records and evaluates the feasibility of treatment

Step 3

Video consultation

Face to face communication with experts to determine treatment plans

Step 4

Treatment in China

Dedicated personnel to pick up and accompany medical treatment throughout the process

Step 5

Rehabilitation follow-up

Postoperative rehabilitation guidance and regular follow-up visits

Remote Consultation

Remote expert evaluation

Make scientific assessment your first step in cross-border healthcare

Provide examination reports/medical records within 30 days

Organize and analyze your past medical records and examination reports
Organize top experts in relevant fields to conduct feasibility assessments
Provide detailed treatment plans and recommendations
Recommend the most suitable hospital and experts
Estimated treatment cost and duration

Click to contact online customer service

Note: The evaluation fee does not include subsequent treatment costs and is only used for expert evaluation services.

Service Process

1
Contact your online service advisor
2
Upload your medical record information
3
Experts complete the assessment within 48 hours
4
Arrange video consultation (30 minutes)
5
Obtain a written treatment plan

48h Response

Top Experts

Secure Payment

Get In Touch

Contact Us

We are always ready to assist you

PrimePath The direct path to advanced healthcare in China

about.positioningText...

service items

About Us

Customer Support